$RXMD Much of this additional interest has been driven by the Company’s ensuing conference call discussion, which focused on Progressive Care’s broader strategic realignment toward a scalable model with national reach, including its coming transformation from a pharmacy model to a comprehensive health services model that includes significant expansion in products and services, including RXMD Therapeutics branded products in the CBD and nutraceutical space, as well as a defining expansion into the Telehealth marketplace.

“As we scale up our current model and target significant new strategic initiatives in the coming months, we feel a duty to our shareholders to ensure both transparency and visibility are elevated to a commensurate degree,” stated S. Parikh Mars, Progressive Care CEO. “We have a potent message and a great story, and it is our responsibility to implement a strategy that communicates that story to our shareholders and the wider investment community.”

https://seekingalpha.com/pr/17722112-progress...d-get-push